Search Legislation

The Health Service Products (Provision and Disclosure of Information) Regulations 2018

What Version

 Help about what version
  • Latest available (Revised)
  • Original (As made)

Status:

This is the original version (as it was originally made). This item of legislation is currently only available in its original format.

Regulation 34

SCHEDULE 4Disclosure of information under section 246B of the 2006 Act: prescribed bodies and prescribed purposes

This schedule has no associated Explanatory Memorandum

1.—(1) The bodies specified in column 1 of Table 1, being bodies appearing to the Secretary of State to represent UK producers, are prescribed for the purposes of section 264B(1)(k) of the 2006 Act.

(2) The purpose for which a body specified in column 1 of Table 1 may use confidential or commercially sensitive information disclosed to it under section 264B(1) of the 2006 Act is the purpose prescribed in the corresponding entry in column 2 of that Table.

Table 1

Column 1 – BodiesColumn 2 – The purpose for which information disclosed under section 264B(1) of the 2006 Act may be used

Association of British Healthcare Industries;

Association of Pharmaceutical Specials Manufacturers;

British Association of European Pharmaceutical Distributors;

British Generic Manufacturers Association;

British Healthcare Trades Association;

British In Vitro Diagnostics Association;

Healthcare Distribution Association;

NHS Pharmacy Production Committee;

NHS Pharmaceutical Quality Assurance;

Proprietary Association of Great Britain;

Surgical Dressings Manufacturers Association Committee;

Urology Trade Association.

The purpose is that of exercising functions connected with any of the matters specified in section 264A(3)(a) to (l).

Association of Independent Multiple Pharmacies;

Company Chemists’ Association;

National Pharmacy Association.

The purpose is that of exercising functions connected with any of the matters specified in section 264A(3)(a) to (k).

BioIndustry Association;

Ethical Medicines Industry Group.

The purpose is that of exercising functions connected with any of the matters specified in section 264A(3)(c), (e), (g), (i), (l) and (m).
Association of the British Pharmaceutical IndustryThe purpose is that of exercising functions connected with any of the matters specified in section 264A(3)(c), (e), (g), (i) and (k) to (m).

British Medical Association;

Dispensing Doctor’s Association.

The purpose is that of exercising functions connected with any of the matters specified in section 264A(3)(a), (c), (d), (f), (g) and (i) to (k).
Pharmaceutical Services Negotiating CommitteeThe purpose is that of exercising functions connected with any of the matters specified in section 264A(3)(b) and (c).

2.—(1) The bodies specified in column 1 of Table 2 are prescribed for the purposes of section 264B(1)(l) of the 2006 Act.

(2) The purpose for which a body specified in column 1 of Table 2 may use confidential or commercially sensitive information disclosed to it under section 264B(1) of the 2006 Act is the purpose prescribed in the corresponding entry in column 2 of that Table.

Table 2

Column 1 – BodiesColumn 2 – Purpose for which information disclosed under section 264B(1) of the 2006 Act may be used

Any NHS foundation trust;

Any NHS trust established under the 2006 Act;

Any clinical commissioning group.

The purpose is that of exercising functions connected with any of the matters specified in section 264A(3)(c).

Any NHS trust established under the 2006 Wales Act;

Any Local Health Board.

The purpose is that of exercising functions connected with any of the matters specified in section 264A(3)(f).
Any Health Board constituted under section 2 of the 1978 ActThe purpose is that of exercising functions connected with any of the matters specified in section 264A(3)(i).
The Regional Health and Social Care Board established under section 7 of the Health and Social Care (Reform) Act Northern Ireland 2009(1)The purpose is that of exercising functions connected with any of the matters specified in section 264A(3)(k).

Back to top

Options/Help

Print Options

Close

Legislation is available in different versions:

Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.

Original (As Enacted or Made):The original version of the legislation as it stood when it was enacted or made. No changes have been applied to the text.

Close

Opening Options

Different options to open legislation in order to view more content on screen at once

Close

Explanatory Memorandum

Explanatory Memorandum sets out a brief statement of the purpose of a Statutory Instrument and provides information about its policy objective and policy implications. They aim to make the Statutory Instrument accessible to readers who are not legally qualified and accompany any Statutory Instrument or Draft Statutory Instrument laid before Parliament from June 2004 onwards.

Close

More Resources

Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:

  • the original print PDF of the as enacted version that was used for the print copy
  • lists of changes made by and/or affecting this legislation item
  • confers power and blanket amendment details
  • all formats of all associated documents
  • correction slips
  • links to related legislation and further information resources
Close

Impact Assessments

Impact Assessments generally accompany all UK Government interventions of a regulatory nature that affect the private sector, civil society organisations and public services. They apply regardless of whether the regulation originates from a domestic or international source and can accompany primary (Acts etc) and secondary legislation (SIs). An Impact Assessment allows those with an interest in the policy area to understand:

  • Why the government is proposing to intervene;
  • The main options the government is considering, and which one is preferred;
  • How and to what extent new policies may impact on them; and,
  • The estimated costs and benefits of proposed measures.
Close

More Resources

Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:

  • the original print PDF of the as made version that was used for the print copy
  • correction slips

Click 'View More' or select 'More Resources' tab for additional information including:

  • lists of changes made by and/or affecting this legislation item
  • confers power and blanket amendment details
  • all formats of all associated documents
  • links to related legislation and further information resources